Jan 9 (Reuters) – Life sciences firm Qiagen said on Monday it has acquired DNA-biometrics firm Verogen in a $150-million cash deal, strengthening its forensics portfolio.
The deal builds on the companies’ existing partnership from 2021, under which Qiagen has the rights to distribute some of Verogen’s products such as its next-generation gene sequencing panels and genetic code analyzing technology GEDmatch.
{iframe}https://www.yahoo.com/now/qiagen-acquires-dna-biometrics-firm-070001725.html{/iframe}